Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS)

✍ Scribed by Khatri, B.O.; Pelletier, J.; Kappos, L.; Hartung, H.-P.; Comi, G.; Barkhof, F.; von Rosenstiel, P.; Meng, X.; Grinspan, A.; Hashmonay, R.; Cohen, J.A.

• Book ID: 121844452
• Publisher: Elsevier
• Year: 2014
• Tongue: English
• Weight: 600 KB
• Volume: 3
• Category: Article
• ISSN: 2211-0348
• DOI: 10.1016/j.msard.2013.11.006